Search research articles
Contact Us
Filters
Showing results (141-150 of 152) with videos related to
Page
of 16
Sort By:
Frontiers in Oncology
|
May 28, 2021
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9
Roman O Kowalchuk, Scott C Lester, Rondell P Graham, et al.
Annals of Surgical Oncology
|
March 11, 2025
Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study
Jennifer L Leiting, Roberto Alva-Ruiz, Jennifer A Yonkus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 7, 2019
Safety, Diagnostic Accuracy, and Effects of Endoscopic Ultrasound Fine-Needle Aspiration on Detection of Extravascular Migratory Metastases
Tarun Rustagi, Ferga C Gleeson, Suresh T Chari, et al.
Journal of Surgical Oncology
|
June 2, 2026
Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage Fluid
Krystal Mills, Calise K Berger, William R Taylor, et al.
Journal of Hepatology
|
September 26, 2022
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma
Caitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
Amro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.
Hepatology (Baltimore, Md.)
|
September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target
Dong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
Hepatology Communications
|
November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> Ga
Scott M Thompson, Garima Suman, Michael S Torbenson, et al.
Annals of Surgery
|
October 20, 2023
An APRI+ALBI-Based Multivariable Model as a Preoperative Predictor for Posthepatectomy Liver Failure
Jonas Santol, Sarang Kim, Lindsey A Gregory, et al.
Cancer Discovery
|
June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
Gadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 152) with videos related to
Sort By:
Page
of 16
Frontiers in Oncology
|
May 28, 2021
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9
Roman O Kowalchuk, Scott C Lester, Rondell P Graham, et al.
Annals of Surgical Oncology
|
March 11, 2025
Molecular KRAS ctDNA Predicts Metastases and Survival in Pancreatic Cancer: A Prospective Cohort Study
Jennifer L Leiting, Roberto Alva-Ruiz, Jennifer A Yonkus, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 7, 2019
Safety, Diagnostic Accuracy, and Effects of Endoscopic Ultrasound Fine-Needle Aspiration on Detection of Extravascular Migratory Metastases
Tarun Rustagi, Ferga C Gleeson, Suresh T Chari, et al.
Journal of Surgical Oncology
|
June 2, 2026
Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage Fluid
Krystal Mills, Calise K Berger, William R Taylor, et al.
Journal of Hepatology
|
September 26, 2022
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma
Caitlin B Conboy, Jennifer A Yonkus, EeeLN H Buckarma, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2022
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma
Amro M Abdelrahman, Ajit H Goenka, Roberto Alva-Ruiz, et al.
Hepatology (Baltimore, Md.)
|
September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target
Dong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
Hepatology Communications
|
November 16, 2021
PSMA as a Theranostic Target in Hepatocellular Carcinoma: Immunohistochemistry and <sup>68</sup> Ga-PSMA-11 PET Using Cyclotron-Produced <sup>68</sup> Ga
Scott M Thompson, Garima Suman, Michael S Torbenson, et al.
Annals of Surgery
|
October 20, 2023
An APRI+ALBI-Based Multivariable Model as a Preoperative Predictor for Posthepatectomy Liver Failure
Jonas Santol, Sarang Kim, Lindsey A Gregory, et al.
Cancer Discovery
|
June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
Gadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Page
of 16